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The remarkable successes achieved using combination
therapy to treat systemic human immunodeficiency virus
type 1 (HIV-1) infection suggest that combination micro-
bicides, which include two or more active ingredients,
may also provide a particularly effective means to prevent
HIV-1 transmission. We have recently identified the com-
pound PSMA, an alternating copolymer of polystyrene
(PS) and maleic anhydride (MA), as a potential partner
for our candidate microbicide polyethylene hexamethyl-
ene biguanide (PEHMB), a member of the polybiguanide
family of compounds. In vitro studies of PSMA demon-
strated that this compound is minimally cytotoxic and
highly effective against both macrophage- and T cell-
tropic strains of HIV-1. We hypothesize that the dissimilar
mechanisms of action of PSMA and PEHMB may provide
additive or synergistic activity against HIV-1. Experiments
are now underway to identify optimal combinations of
PSMA and PEHMB to be used in experiments to assess tox-
icity, anti-HIV-1 activity, and formulation strategies.
These investigations will be used to confidently advance
the preclinical development of PSMA and a combination
microbicide containing both compounds toward human
trials.
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